An analysis of GLP-1R mRNA in patients with PD showed a 10-fold increase in the SN (Yun et al., 2018), indicating that GLP-1 levels in the brain are reduced, which leads to an upregulation of the receptor. This evidence concerns the gene GLP1R and Parkinson disease.